Compare · ACCD vs BOWX
ACCD vs BOWX
Side-by-side comparison of Accolade Inc. (ACCD) and BowX Acquisition Corp. (BOWX): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while BOWX operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 1.9x BOWX ($606.8M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for BOWX).
- Company
- Accolade Inc.
- BowX Acquisition Corp.
- Price
- $7.03+0.00%
- $10.37+10.27%
- Market cap
- $1.18B
- $606.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
BowX Acquisition Corp.
Bowx Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It primarily focuses on businesses in the technology, media, and telecommunications industries. The company was incorporated in 2020 and is based in Menlo Park, California.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest BOWX
- SEC Form 3 filed by new insider Dunlevie Bruce
- SEC Form 4 filed by Hashemi Hamid
- SEC Form 4: Morey Scott was granted 289,166 shares
- SEC Form 4 filed by Sole-Rafols Roger
- SEC Form 4: Kazanjian Maral was granted 113,037 shares
- SEC Form 4: Wehner Kurt was granted 59,898 shares
- SEC Form 4: Yazbeck Anthony was granted 346,264 shares
- SEC Form 4: Dematteis Jared gave a grant of 190,461 shares, increasing direct ownership by 14,047% to 123,928 units
- SEC Form 4: Fritts Lauren was granted 21,480 shares
- SEC Form 4: Mathrani Sandeep was granted 1,734,999 shares